文献速递心外重症与机械循环支持

体外膜氧合支持患者的感染回顾性研究

A Retrospective Study of Infection in Patients Requiring Extracorporeal Membrane Oxygenation Support.
PubMed 文献 · Ann Thorac Surg · 2020-12-24

该研究回顾了2015至2017年单一ECMO转诊中心288例成人ECMO患者,比较感染与非感染患者结局,并与CSICU非ECMO患者及ELSO数据对照。结果显示ECMO患者菌血症发生率显著高于非ECMO CSICU患者(7.6% vs 1.5%,P < .002),感染与VA-ECMO生存下降及ECMO支持时间延长相关。

要点

  • ECMO患者菌血症发生率7.6%,显著高于非ECMO CSICU患者的1.5%。
  • 菌血症和肺炎与VA-ECMO生存下降及ECMO支持时间延长相关。
  • 拔管后3个月内感染风险仍显著。

核心结论

  • ECMO患者院内感染发生率显著高于其他CSICU患者。
  • 感染与死亡率增加及ECMO支持时间延长相关。
  • 拔管后感染风险仍显著。

研究设计与样本

  • 共288例ECMO患者和3396例CSICU入住病例。
  • 收集人口学、诊断、ECMO插管技术和生存数据,以及ECMO期间和拔管后3个月内尿路感染、肺炎和菌血症发生率。

主要发现

  • 静脉-动脉ECMO生存率72.3%,静脉-静脉ECMO生存率85.3%,多模式或静脉-动脉-静脉ECMO生存率57.1%。
  • 出院生存率分别为60.2%、72.0%和28.6%。
  • 插管期间菌血症发生率静脉-动脉ECMO为6.8%,静脉-静脉ECMO为9.3%。
  • 288例ECMO患者中22例(7.6%)发生菌血症,非ECMO CSICU患者3109例中48例(1.5%)发生菌血症,差异有统计学意义(P < .002)。
  • 菌血症和肺炎与VA-ECMO生存下降及ECMO支持总体需求延长相关。

临床怎么用

  • 应加强ECMO患者院内感染监测,尤其关注菌血症和肺炎。
  • 拔管后3个月内仍需警惕感染风险。
  • 需进一步研究降低ECMO高危人群院内感染策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Healthcare-associated infections (HAIs) in critically ill patients are a serious public health problem. Extracorporeal membrane oxygenation (ECMO) has been used increasingly for patients with severe cardiac or respiratory failure, but it may increase HAI risk. The goal of our study was to characterize HAIs in ECMO patients at an ECMO referral center. METHODS: This institutional review board-approved study identified all consecutive adult ECMO patients admitted to the cardiac surgery intensive care unit (CSICU) between January 1, 2015, and December 31, 2017. Demographic data, diagnosis, ECMO cannulation technique, and survival were collected. Urinary tract infection, pneumonia, and bacteremia incidence during ECMO and within 3 months of decannulation were collected. Outcomes of patients with HAIs were compared with noninfected patients, the CSICU infection incidence, and overall Extracorporeal Life Support Organization survival data. RESULTS: There were 288 ECMO patients and 3396 CSICU admissions during this period. Survival was 72.3% for venoarterial ECMO, 85.3% for venovenous ECMO, and 57.1% for multimodality or veno-arteriovenous ECMO, with discharge survival of 60.2%, 72.0%, and 28.6%, respectively. Bacteremia incidence while cannulated was 6.8% for venoarterial ECMO and 9.3% for venovenous ECMO. Bacteremia occurred in 22 of 288 (7.6%) ECMO patients, compared with 48 of 3109 (1.5%) in non-ECMO CSICU patients, which was statistically significant (P < .002). Bacteremia and pneumonia were associated with decreased VA-ECMO survival, with prolonged overall requirements for ECMO support. CONCLUSIONS: Nosocomial ECMO infections are significantly higher than in other CSICU patients. Infection risk remains significant even after decannulation. Infection is associated with increased mortality and longer duration of ECMO support. Further efforts are needed to determine HAI reduction strategies in this high-risk patient population.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Quintana MT, Mazzeffi M, Galvagno SM, et al. A Retrospective Study of Infection in Patients Requiring Extracorporeal Membrane Oxygenation Support. Ann Thorac Surg. 2020. PMID: 33359722. doi:10.1016/j.athoracsur.2020.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。